The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
A Gozzetti, E Capochiani, M Bocchia - Leukemia, 2020 - nature.com
With great interest, we had the opportunity to read the paper by La Rosée F et al.[1] in which
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
A Gozzetti, E Capochiani, M Bocchia - Leukemia, 2020 - ncbi.nlm.nih.gov
With great interest, we had the opportunity to read the paper by La Rosée F et al.[1] in which
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
A Gozzetti, E Capochiani, M Bocchia - Leukemia, 2020 - europepmc.org
With great interest, we had the opportunity to read the paper by La Rosée F et al.[1] in which
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
[引用][C] The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
A Gozzetti, E Capochiani, M Bocchia - LEUKEMIA, 2020 - usiena-air.unisi.it
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …
[引用][C] The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
A Gozzetti, E Capochiani, M Bocchia - Leukemia, 2020 - pubmed.ncbi.nlm.nih.gov
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 The Janus kinase 1/2 inhibitor ruxolitinib
in COVID-19 Leukemia. 2020 Oct;34(10):2815-2816. doi: 10.1038/s41375-020-01038-8. Epub …
in COVID-19 Leukemia. 2020 Oct;34(10):2815-2816. doi: 10.1038/s41375-020-01038-8. Epub …
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
A Gozzetti, E Capochiani, M Bocchia - Leukemia, 2020 - go.gale.com
With great interest, we had the opportunity to read the paper by La Rosée F et al.[1] in which
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …
between March 30th and April 15th, 2020, using a newly developed COVID-19 Inflammation …